Allogene Therapeutics, Inc. (NASDAQ:ALLO) IPO

Allogene Therapeutics, Inc.

IPO

Priced at US$18.00 a share on Oct 10, 2018.

Price
US$18.00 a share
Shares offered
18,000,000 shares of common stock
Offering size
US$324 million
Underwriters' option
Up to 2,700,000 more shares
Underwriters
Goldman Sachs & Co. LLC, J.P. Morgan, Cowen, Jefferies · In the order on the cover

Steps

StepWhen
Draft sent to the SEC in confidenceAug 10, 2018
Filed publiclySep 14, 2018
Amended 3 timesNewest Oct 5, 2018
Shares registered with an exchangeOct 5, 2018
Declared effective by the SECOct 10, 2018
Final prospectus, with the priceOct 11, 2018

From the cover of the final prospectus (424B4) filed Oct 11, 2018